However, patients may experience spotting due to other factors, including weight loss-induced hormonal changes, contraceptive interactions, or underlying gynecological conditions
Reaction rates vary by product and doseclinical trials of semaglutide reported injection site reactions in approximately 1-2% of patients, while other medications may show different rates
RT-PCR was conducted using the SYBR Green method on a real-time PCR system
Chronic pain often involves nervous system sensitization, metabolic dysfunction, nutrient depletion, or low-grade inflammation that may not appear on standard imaging or routine laboratory tests
We stand apart by integrating advanced GLP-1 therapies (Semaglutide/Tirzepatide) with a holistic approach, providing continuous medical oversight and customized planning